HOXA13 and neoplasm: Mechanistically, YTHDC2 decreased homeobox A13 (HOXA13) mRNA stability by recognizing the m6A site in the 3′-UTR to suppress SLC3A2 expression, thereby inhibiting LUAD antioxidation and further limiting tumor progression.